Ischemia-reperfusion injury: Processes in pathogenetic networks: A review

被引:218
作者
de Groot, H. [1 ]
Rauen, U. [1 ]
机构
[1] Univ Klinikum Essen, Inst Physiol Chem, D-45122 Essen, Germany
关键词
D O I
10.1016/j.transproceed.2006.12.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ischemia-reperfusion injury is a complex phenomenon involving not only intracellular injury processes but also an injurious inflammatory response. Both the intracellular injury processes and the injurious events of the inflammatory response are interconnected in pathogenetic networks. Anoxic cell injury predominates in the ischemic phase. The decreased mitochondrial AT? generation impairs cellular ion homeostasis with activation of hydrolases and loss of selective permeability of cell membranes. Upon resupply of blood, the inflammatory response is initiated. Resident cells of the affected tissue, blood-derived cells, and noncellular elements such as the complement system are activated, and signalling and other molecules are formed at altered rates. Cell injury occurring in the reperfusion phase may either be a consequence of cellular alterations that were already initiated in the ischemic phase or may result from the inflammatory response. The intracellular injurious alterations are in part the same as those involved in anoxic cell injury. In addition, activation of intracellular signalling cascades and of apoptotic pathways may take place. Except for a large decrease in their rates, no significant difference exists between the injury processes during warm and cold ischemia as they become evident during ischemia itself. In contrast, the injury processes of the inflammatory response and of cell injury in the reperfusion phase significantly vary depending on pre-existent warm versus cold ischemia. Because of the netlike characteristics of the pathomechanisms, a multifactorial approach is required to provide protection against ischemia-reperfusion injury.
引用
收藏
页码:481 / 484
页数:4
相关论文
共 13 条
[1]   Myocardial ischemia and reperfusion injury [J].
Buja, LM .
CARDIOVASCULAR PATHOLOGY, 2005, 14 (04) :170-175
[2]   Blocking the path to death: Anti-apoptotic molecules in ischemia/reperfusion injury of the liver [J].
Georgiev, P. ;
Dahm, F. ;
Graf, R. ;
Clavien, P. -A. .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (23) :2911-2921
[3]  
Hoffman John W Jr, 2004, J Extra Corpor Technol, V36, P391, DOI 10.1051/ject/2004364391
[4]   Mitochondria and ischemia/reperfusion injury [J].
Honda, HM ;
Korge, P ;
Weiss, JN .
COMMUNICATIVE CARDIAC CELL, 2005, 1047 :248-258
[5]   Pathophysiology and therapy of experimental stroke [J].
Konstantin-Alexander Hossmann .
Cellular and Molecular Neurobiology, 2006, 26 (7) :1057-1083
[6]   Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning [J].
Jaeschke, H .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2003, 284 (01) :G15-G26
[7]   The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation [J].
Land, WG .
TRANSPLANTATION, 2005, 79 (05) :505-514
[8]   Reactive species mechanisms of cellular hypoxia-reoxygenation injury [J].
Li, CY ;
Jackson, RM .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2002, 282 (02) :C227-C241
[9]   Apoptosis and necrosis in the liver: A tale of two deaths? [J].
Malhi, H ;
Gores, GJ ;
Lemasters, JJ .
HEPATOLOGY, 2006, 43 (02) :S31-S44
[10]   Pathophysiology of stroke: Lessons from animal models [J].
Mergenthaler, P ;
Dirnagl, U ;
Meisel, A .
METABOLIC BRAIN DISEASE, 2004, 19 (3-4) :151-167